Frankfurt-based medical marijuana company Bloomwell Group Gmbh released a survey on cannabis consumption in Germany showing 94% of respondents use cannabis for at least one health reason. Stress relief was the most common reason (60%), followed by sleeping disorders (50.4%) and pain relief (35%). “The responses illustrate the immense potential and room for growth of the country’s rapidly expanding medical cannabis industry following the implementation of the Cannabis Act (CanG) on April 1, 2024, which rescheduled cannabis as a non-narcotic,” stated Niklas Kouparanis, co-founder and CEO of the …